Supportive Care in Cancer,
Journal Year:
2024,
Volume and Issue:
32(8)
Published: July 30, 2024
Advances
in
the
treatment
of
cancer
have
significantly
improved
mortality
rates;
however,
this
has
come
at
a
cost,
with
many
treatments
still
limited
by
their
toxic
side
effects.
Mucositis
both
mouth
and
gastrointestinal
tract
is
common
following
anti-cancer
agents,
manifesting
as
ulcerative
lesions
associated
symptoms
throughout
alimentary
tract.
The
pathogenesis
mucositis
was
first
defined
2004
Sonis,
almost
20
years
on,
model
continues
to
be
updated
reflecting
ongoing
research
initiatives
more
sophisticated
analytical
techniques.
most
recent
update,
published
Multinational
Association
for
Supportive
Care
Cancer
International
Society
Oral
Oncology
(MASCC/ISOO),
highlights
numerous
co-occurring
events
that
underpin
development.
Most
notably,
role
ecosystem
microorganisms
reside
(the
oral
gut
microbiota)
explored,
building
on
initial
concepts
proposed
Sonis.
However,
questions
remain
regarding
true
causal
contribution
microbiota
metabolome.
This
review
aims
provide
an
overview
rapidly
evolving
area,
synthesizing
current
evidence
microbiota's
development
progression,
highlighting
(i)
components
5-phase
where
microbiome
may
involved,
(ii)
methodological
challenges
hindered
advances
(iii)
opportunities
intervention.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(2), P. 356 - 356
Published: Jan. 11, 2023
The
current
study
aims
to
evaluate
the
potential
roles
of
taking
probiotics
postoperatively
in
attenuating
gastrointestinal
complications
and
disturbed
gut
microbiota
colorectal
cancer
(CRC)
patients
undergoing
chemotherapy.
One
hundred
eligible
CRC
who
were
treated
with
radical
surgery
needed
receive
chemotherapy
recruited.
Half
them
randomly
assigned
Probio
group
take
a
probiotic
combination
from
post-operation
end
first
chemotherapeutic
course.
other
half
placebo
instead
classified
as
Placebo
group.
Gastrointestinal
such
nausea,
acid
reflux,
abdominal
pain,
distention,
constipation,
diarrhea
recorded
during
Fecal
samples
collected
preoperatively
after
cycle
postoperative
for
16S
rRNA
high-throughput
sequencing
short-chain
fatty
acids
(SCFAs)
analysis.
Results
showed
that
administration
could
effectively
reduce
chemotherapy-induced
complications,
particularly
(p
<
0.01).
Additionally,
also
reduced
bacterial
diversity
indexes
patients,
which
be
significantly
increased
by
probiotics.
Moreover,
this
caused
significant
changes
composition
microbiota,
indicated
decreased
phylum
levels
Firmicutes
Bacteroidetes,
Proteobacteria,
Verrucomicrobia.
In
particular,
several
genera
Akkermansia
Clostridium
increased,
while
Prevotella,
Lactobacillus,
Roseburia
0.05).
However,
restore
these
taxa
both
at
genus
levels,
mildly
increase
Bifidobacterium,
Streptococcus,
Blautia.
Furthermore,
promote
production
SCFAs,
increasing
acetate,
butyrate,
propionate
0.0001).
These
results
support
beneficial
effects
interventions
novel
alternative
or
complementary
strategies
chemoprevention.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
165, P. 115276 - 115276
Published: Aug. 4, 2023
Short-chain
fatty
acids
(SCFAs)
derived
from
the
fermentation
of
carbohydrates
by
gut
microbiota
play
a
crucial
role
in
regulating
host
physiology.
Among
them,
acetate,
propionate,
and
butyrate
are
key
players
various
biological
processes.
Recent
research
has
revealed
their
significant
functions
immune
inflammatory
responses.
For
instance,
reduces
development
interferon-gamma
(IFN-γ)
generating
cells
while
promoting
regulatory
T
(Treg)
cells.
Propionate
inhibits
initiation
Th2
response
dendritic
(DCs).
Notably,
SCFAs
have
an
inhibitory
impact
on
polarization
M2
macrophages,
emphasizing
immunomodulatory
properties
potential
for
therapeutics.
In
animal
models
asthma,
both
propionate
suppress
pathway,
thus
reducing
allergic
airway
inflammation.
Moreover,
dysbiosis
leading
to
altered
SCFA
production
been
implicated
prostate
cancer
progression.
trigger
autophagy
promote
accelerating
tumor
advancement.
Manipulating
microbiota-
producing
holds
promise
treatment.
Additionally,
enhance
expression
hypoxia-inducible
factor
1
(HIF-1)
blocking
histone
deacetylase,
resulting
increased
antibacterial
effectors
improved
macrophage-mediated
elimination
microorganisms.
This
highlights
antimicrobial
defense
mechanisms.
comprehensive
review
provides
in-depth
analysis
latest
functional
aspects
underlying
mechanisms
relation
macrophage
activities
wide
range
diseases,
including
infectious
diseases
cancers.
By
elucidating
intricate
interplay
between
functions,
this
aims
contribute
understanding
therapeutic
pave
way
future
interventions
targeting
disease
management.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Aug. 7, 2023
Abstract
Colorectal
cancer
(CRC)
therapy
efficiency
can
be
influenced
by
the
microbiota
in
gastrointestinal
tract.
Compared
with
traditional
intervention,
prebiotics
delivery
into
gut
is
a
more
controllable
method
for
modulatory
therapy.
Capecitabine
(Cap),
first-line
chemotherapeutic
agent
CRC,
lacks
carrier
that
prolong
its
half-life.
Here,
we
construct
Cap-loaded
nanoparticle
using
prebiotic
xylan-stearic
acid
conjugate
(SCXN).
The
oral
administration
of
SCXN
delays
drug
clearance
blood
and
increases
intra-tumoral
Cap
concentration
CRC
mouse
model.
also
facilitates
probiotic
proliferation
short
chain
fatty
production.
free
Cap,
enhances
anti-tumor
immunity
tumor
inhibition
rate
from
5.29
to
71.78%.
exhibits
good
biocompatibility
prolongs
median
survival
time
mice
14
33.5
d.
This
prebiotics-based
provides
promising
treatment
combining
modulation
chemotherapy.
BMC Microbiology,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Jan. 5, 2024
Abstract
Studying
the
effects
of
microbiome
on
development
different
types
cancer
has
recently
received
increasing
research
attention.
In
this
context,
microbial
content
organs
gastrointestinal
tract
been
proposed
to
play
a
potential
role
in
pancreatic
(PC).
Proposed
mechanisms
for
pathogenesis
PC
include
persistent
inflammation
caused
by
microbiota
leading
an
impairment
antitumor
immune
surveillance
and
altered
cellular
processes
tumor
microenvironment.
The
limited
available
diagnostic
markers
that
can
currently
be
used
screening
suggest
importance
composition
as
non-invasive
biomarker
clinical
settings.
Samples
including
saliva,
stool,
blood
analyzed
16
s
rRNA
sequencing
determine
relative
abundance
specific
bacteria.
Studies
have
shown
potentially
beneficial
prebiotics,
probiotics,
antibiotics,
fecal
transplantation,
bacteriophage
therapy
altering
diversity,
subsequently
improving
treatment
outcomes.
review,
we
summarize
impact
PC,
these
microorganisms
might
biomarkers
diagnosis
determining
prognosis
patients.
We
also
discuss
novel
methods
being
minimize
or
prevent
progression
dysbiosis
modulating
composition.
Emerging
evidence
is
supportive
applying
findings
improve
current
therapeutic
strategies
employed
PC.
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 270 - 270
Published: Feb. 12, 2025
The
gut-brain-cancer
axis
represents
a
novel
and
intricate
connection
between
the
gut
microbiota,
neurobiology,
cancer
progression.
Recent
advances
have
accentuated
significant
role
of
microbiota
metabolites
in
modulating
systemic
processes
that
influence
both
brain
health
tumorigenesis.
This
paper
explores
emerging
concept
metabolite-mediated
modulation
within
connection,
focusing
on
key
such
as
short-chain
fatty
acids
(SCFAs),
tryptophan
derivatives,
secondary
bile
acids,
lipopolysaccharides
(LPS).
While
microbiota's
impact
immune
regulation,
neuroinflammation,
tumor
development
is
well
established,
gaps
remain
grasping
how
specific
contribute
to
neuro-cancer
interactions.
We
discuss
with
potential
implications
for
neurobiology
cancer,
indoles
polyamines,
which
yet
be
extensively
studied.
Furthermore,
we
review
preclinical
clinical
evidence
linking
dysbiosis,
altered
metabolite
profiles,
tumors,
showcasing
limitations
research
gaps,
particularly
human
longitudinal
studies.
Case
studies
investigating
microbiota-based
interventions,
including
dietary
changes,
fecal
transplantation,
probiotics,
demonstrate
promise
but
also
indicate
hurdles
translating
these
findings
therapies.
concludes
call
standardized
multi-omics
approaches
bi-directional
frameworks
integrating
microbiome,
neuroscience,
oncology
develop
personalized
therapeutic
strategies
patients.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2023,
Volume and Issue:
64(29), P. 10885 - 10902
Published: July 6, 2023
Resistant
starch,
also
known
as
anti-digestion
enzymatic
which
cannot
be
digested
or
absorbed
in
the
human
small
intestine.
It
can
fermented
large
intestine
into
short-chain
fatty
acids
(SCFAs)
and
metabolites,
are
advantageous
to
body.
Starches
classify
rapidly
digestible
starch
(RDS),
slowly
(SDS),
resistant
(RS),
possess
high
thermal
stability,
low
water
holding
capacity,
emulsification
characteristics.
has
excellent
physiological
functions
such
stabilizing
postprandial
blood
glucose
levels,
preventing
type
II
diabetes,
intestinal
inflammation,
regulating
gut
microbiota
phenotype.
is
extensively
utilized
food
processing,
delivery
system
construction,
Pickering
emulsion
due
its
processing
properties.
The
starches,
with
their
higher
resistance
hydrolysis,
support
suitability
a
potential
drug
carrier.
Therefore,
this
review
focuses
on
structural
features,
modification
characteristics,
immunomodulatory
functions,
applications.
objective
was
provide
theoretical
guidance
for
applying
of
health
related
industries.
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(3), P. 662 - 662
Published: March 6, 2023
Chlamydia
trachomatis
and
human
papillomavirus
(HPV)
are
the
most
common
pathogens
found
in
sexually
transmitted
infections
(STIs),
both
known
to
increase
risk
of
cervical
cancer
(CC)
infertility.
HPV
is
extremely
worldwide,
scientists
use
it
distinguish
between
low-risk
high-risk
genotypes.
In
addition,
transmission
can
occur
via
simple
contact
genital
area.
From
50
80%
active
individuals
become
infected
with
C.
viruses
during
their
lifetime,
up
50%
an
oncogenic
genotype.
The
natural
history
this
coinfection
strongly
conditioned
by
balance
host
microbiome
immune
condition
infecting
agent.
Though
infection
often
regresses,
tends
persist
throughout
adult
life
asymptomatically
silently.
partnership
basically
due
similarities:
routes,
reciprocal
advantages,
same
factors.
a
Gram-negative
bacteria,
similar
HPV,
intracellular
bacterium,
which
shows
unique
biphasic
development
that
helps
latter
continue
its
steady
progression
into
entire
life.
Indeed,
depending
on
individual’s
condition,
migrate
toward
upper
tract
spread
uterus,
fallopian
tubes
open
pathway
invasion.
related
female
facilitated
decay
first
line
defense
vaginal
environment,
constituted
healthy
characterized
net
equilibrium
all
components.
Thus,
aim
paper
was
highlight
complexity
fragility
microenvironment
accentuate
fundamental
role
elements
systems
involved,
including
Lactobacillus
strains
(Lactobacillus
gasseri,
jensenii,
crispatus)
immune–endocrine
system,
preserving
from
mutation.
Therefore,
age,
diet,
genetic
predisposition
together
unspecific,
persistent
low-grade
inflammatory
state
were
be
implicated
high
frequency
severity
grade
disease,
potentially
resulting
pre-cancerous
cancerous
lesions.
Cancers,
Journal Year:
2024,
Volume and Issue:
16(3), P. 676 - 676
Published: Feb. 5, 2024
Traditionally
considered
a
disease
common
in
the
older
population,
colorectal
cancer
is
increasing
incidence
among
younger
demographics.
Evidence
suggests
that
populational-
and
generational-level
shifts
composition
of
human
gut
microbiome
may
be
tied
to
recent
trends
gastrointestinal
carcinogenesis.
This
review
provides
an
overview
current
research
putative
mechanisms
behind
rising
with
insight
into
future
interventions
prevent
or
reverse
rate
early-onset
carcinoma.